Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for KindlyMD, Inc. (NAKA : NSDQ)

• Company Description    KindlyMD Inc. is a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, including the recommendation of medical cannabis in patient treatment plans in compliance with a legalized state medical cannabis regulatory scheme. KindlyMD Inc. is based in SALT LAKE CITY, UT. Number of Employees: 61

• Price / Volume Information    Yesterday's Closing Price: $12.30 Daily Weekly Monthly 20 Day Moving Average: 451,545 shares Shares Outstanding: 6.03 (millions) Market Capitalization: $74.17 (millions) Beta: 35.16 52 Week High: $34.77 52 Week Low: $0.65 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -10.87% -14.90% 12 Week 602.86% 493.15% Year To Date 891.93% 832.02%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5097 SOUTH 900 EAST SUITE 100 - SALT LAKE CITY,UT 84117 USA ph: 385-388-8220 fax: - investors@kindlymd.com https://kindlymd.com

• General Corporate Information    Officers Tim Pickett - Chief Executive Officer and Director Adam Cox - Chief Operating Officer and Director Jared Barrera - Chief Financial and Accounting Officer Amy Powell - Director Christian Robinson - Director Peer Information KindlyMD, Inc. (CHCR) KindlyMD, Inc. (ESRX) KindlyMD, Inc. (MYDP) KindlyMD, Inc. (COR) KindlyMD, Inc. (GBCS) KindlyMD, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 49457M106 SIC: 8000 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/12/25 Share - Related Items Shares Outstanding: 6.03 Most Recent Split Date: (:1) Beta: 35.16 Market Capitalization: $74.17 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/12/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 48.44 Price/Cash Flow: - Price / Sales: 30.01 EPS Growth vs. Year Ago Period: -183.33% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: -30.04% vs. Previous Quarter: -3.97% ROE 06/30/25 - - 03/31/25 - -146.26 12/31/24 - -144.00 ROA 06/30/25 - - 03/31/25 - -109.19 12/31/24 - -101.50 Current Ratio 06/30/25 - - 03/31/25 - 2.30 12/31/24 - 4.14 Quick Ratio 06/30/25 - - 03/31/25 - 2.30 12/31/24 - 4.13 Operating Margin 06/30/25 - - 03/31/25 - -177.01 12/31/24 - -133.01 Net Margin 06/30/25 - - 03/31/25 - -177.01 12/31/24 - -133.01 Pre-Tax Margin 06/30/25 - - 03/31/25 - -177.01 12/31/24 - -133.01 Book Value 06/30/25 - - 03/31/25 - 0.25 12/31/24 - 0.43 Inventory Turnover 06/30/25 - - 03/31/25 - 26.62 12/31/24 - 4.96 Debt-to-Equity 06/30/25 - - 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - - 03/31/25 - 0.46 12/31/24 - 0.30

Powered by Zacks Investment Research ©